Novanta/$NOVT

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Novanta

Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.

Ticker

$NOVT
Primary listing

Industry

Electronic Equipment, Instruments & Components

Employees

3,000

ISIN

CA67000B1040

Novanta Metrics

BasicAdvanced
$4.5B
64.44
$1.95
1.51
-

What the Analysts think about Novanta

Analyst ratings (Buy, Hold, Sell) for Novanta stock.

Bulls say / Bears say

Novanta reported a 12.5% year-over-year revenue increase to $238.1 million in Q3 2024, indicating strong growth in its core markets. (Investing.com)
The company's operating margin has improved by 2.3 percentage points over the last five years, reflecting enhanced operational efficiency. (Stock Story)
Novanta's stock has delivered an annualized return of 31.24% over the past 10 years, significantly outperforming the S&P 500's 11.71% return. (PortfoliosLab)
Novanta's CFO sold over $770,000 worth of company stock in September 2024, which could signal potential concerns about the company's future performance. (Investing.com)
The company missed Q4 sales targets, with revenue growth slowing to 5% over the last two years, below its five-year trend. (Stock Story)
Analysts have downgraded Novanta's price target from $169.00 to $160.00, reflecting tempered expectations for the company's stock performance. (Techdows News)
Data summarised monthly by Lightyear AI. Last updated on 8 Jun 2025.

Novanta Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Novanta Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $NOVT

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs